Drug Development Research

Papers
(The H4-Index of Drug Development Research is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Therapeutic potential and research progress of diosgenin for lipid metabolism diseases96
Safety study of topical naltrexone therapy for diabetic skin wounds is confirmed in Göttingen mini‐pigs84
74
Recent Development in Celiac Disease: Pathophysiology, Animal Models and Treatments63
Research Progress of Endoplasmic Reticulum Targeting Metal Complexes in Cancer Therapy56
A growth‐based assay using fluorescent protein emission to screen for S‐adenosylmethionine synthetase inhibitors52
Trifolirhizin targets PTK6 to induce autophagy and exerts antitumor effects in nasopharyngeal carcinoma47
Knockdown of IGF2BP3 inhibits the tumorigenesis of gallbladder cancer and modifies tumor microenvironment45
Susceptibility of Leishmania to novel pentavalent organometallics: Investigating impact on DNA and membrane integrity in antimony(III)‐sensitive and ‐resistant strains42
Novel matrinic acid derivatives bearing 2‐anilinothiazole structure for non‐small cell lung cancer treatment with improved Hsp90 targeting effect32
Rational Discovery of BACE1‐Selective Inhibitors as Potential Therapeutics for Alzheimer's Disease30
CircRNF121 knockdown suppresses the progression of cervical cancer by regulating miR ‐153‐3p/ ATF2 axis and29
Anti‐inflammatory effect and mechanism of catalpol in various inflammatory diseases28
Synthesis and Biological Evaluation of π‐Conjugated Ir(III) Complexes: Cytotoxic Potential, DNA/HSA Binding, Thermodynamics, and Antioxidant Activity28
Bioinformatics Exploration of the Therapeutic Potential of Lotus Seed Compounds in Multiple Sclerosis: A Network Analysis of c‐Jun Pathway28
Design, synthesis, in vitro, and in vivo evaluation of novel phthalazinone‐based derivatives as promising acetylcholinesterase inhibitors for treatment of Alzheimer's disease27
Recent advancement in drug development of nitro(NO2)‐heterocyclic compounds as lead scaffolds for the treatment of Mycobacterium tuberculosis27
Advancements in Organoid‐Based Drug Discovery: Revolutionizing Precision Medicine and Pharmacology27
Xanthatin induce DDP‐resistance lung cancer cells apoptosis through regulation of GLUT1 mediated ROS accumulation27
Recent research brings hope for reshaping the co‐evolutionary arms race against parasitic infectious diseases25
Issue Information25
New pyrrole derivatives as DNA gyrase and 14α‐demethylase inhibitors: Design, synthesis, antimicrobial evaluation, and molecular docking25
PX‐12 synergistically enhances the therapeutic efficacy of vorinostat under hypoxic tumor microenvironment in oral squamous cell carcinoma in vitro24
Issue Information24
Irisin Protects Against Diabetic Cardiomyopathy by Suppressing Ferroptosis24
0.11914491653442